GO
Loading...

Enter multiple symbols separated by commas

CNBC's Huckman: Glaxo CEO, British Journal Dispute Avandia Study

The CEO of GlaxoSmithKline and a prominent British medical journal are criticizing a recent study that said Glaxo's widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death.

The study, published earlier this week in the New England Journal of Medicine, said results of dozens of studies revealed a 43% higher risk of heart attack for those who took Avandia. Though experts said the overall risk was small and cautioned people not to stop taking the drug, the news sent Glaxo shares down sharply.

Glaxo CEO J.P. Garnier told the Wall Street Journal that he thinks people are over-reacting to the study. Garnier acknowledged that Avandia sales could take a hit but expressed confidence they'll rebound when the full safety data have been analyzed.

His comments came as the British medical journal The Lancet shot down the study in its online edition. The Lancet said "it would be premature to over-interpret" the results until there is a clinical trial specifically designed to look at the heart safety of Avandia.

The Lancet concludes that "to avoid unnecessary panic among patients...a calmer and more considered approach to the safety of Avandia is needed. Alarmist headlines and confident declarations help nobody."

More than six million people worldwide have taken Avandia since it came on the market eight years ago.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Dani Mathers, the 2015 Playmate of the Year, poses during a luncheon on the garden grounds of the Playboy Mansion in Los Angeles, May 14, 2015.

    Playboy on Thursday launched its completely safe-for-work mobile app Playboy NOW, part of a strategy to make more mainstream content.

  • Li Hejun, Hanergy Holding Group

    In the history of sudden wealth loss, Li Hejun may have set a new record.

  • Marc Cuban

    Ask Mark Cuban what the next big thing in technology is, you'll get an answer straight out of a science fiction film.

U.S. Video

  • IBM takes aim at traffic nightmares

    Bob Picciano, IBM svp of analytics, discusses how IBM's smart traffic management system is using hi-tech to tackle traffic jams in New Jersey.

  • Cutting your water bill

    CNBC consumer reporter Kelli Grant offers tips on how to stop wasting water and cut down your water bill.

  • Doing the math on minimum wage

    Joe Watkins, former GHW Bush White House official, and Jimmy Williams, Blue Nation Review, weigh in on the minimum wage debate and whether it hurts small business.